SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2010 on Tuesday, November 9, 2010, after the U.S. financial markets close. ACADIA’s management will host a conference call and webcast on Tuesday, November 9, 2010, at 5:00 p.m. Eastern Time to discuss ACADIA’s financial results and development programs.
